Monotherapy with either Dutasteride or Doxazosin after 2 years of combination therapy in men with benign prostatic hyperplasia: effects on lower urinary tract symptoms.

Trial Profile

Monotherapy with either Dutasteride or Doxazosin after 2 years of combination therapy in men with benign prostatic hyperplasia: effects on lower urinary tract symptoms.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Dec 2013

At a glance

  • Drugs Doxazosin (Primary) ; Dutasteride (Primary)
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top